Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
0.8290
+0.0283 (3.53%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Pomdoctor Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -212.58 | -143.36 | -145.39 | -125.51 | -188.4 |
Depreciation & Amortization | 0.15 | 0.13 | 0.11 | - | 21.32 |
Loss (Gain) From Sale of Assets | - | -0 | - | - | - |
Asset Writedown & Restructuring Costs | 2.11 | 2.24 | 1.11 | - | 24.94 |
Loss (Gain) From Sale of Investments | - | - | 0.5 | - | - |
Stock-Based Compensation | 16.42 | - | - | - | - |
Provision & Write-off of Bad Debts | -0.24 | 0.84 | 1.49 | -0.77 | -0.89 |
Other Operating Activities | 83.53 | 106.49 | 108.94 | 105.68 | 92.22 |
Change in Accounts Receivable | -10.51 | 19.89 | -1.27 | -26.1 | -1.76 |
Change in Inventory | -0.75 | 4.98 | -5.06 | -1.31 | -2.23 |
Change in Accounts Payable | 19.47 | -16.34 | -1.66 | 12.94 | 5.43 |
Change in Unearned Revenue | -0.16 | 0.51 | -1.49 | 1.28 | 1.45 |
Change in Other Net Operating Assets | -45.93 | 8.49 | -3.08 | 11.78 | 32.25 |
Operating Cash Flow | -148.48 | -16.13 | -45.8 | -22.02 | -15.68 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.61 | -0.04 | -0.11 | - | - |
Sale of Property, Plant & Equipment | - | 0 | - | - | - |
Investment in Securities | - | - | - | - | -0.5 |
Investing Cash Flow | -1.61 | -0.03 | -0.11 | - | -0.5 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | 56 | 44.1 | 28 | 10.1 | 9 |
Long-Term Debt Issued | 34.73 | 41.16 | 108.55 | 25.33 | 54.42 |
Total Debt Issued | 90.73 | 85.26 | 136.55 | 35.43 | 63.42 |
Short-Term Debt Repaid | -37.96 | -31.14 | -15.66 | -1.52 | -17.86 |
Long-Term Debt Repaid | -38.71 | -37.1 | -68.55 | -11.41 | -40.13 |
Total Debt Repaid | -76.67 | -68.24 | -84.21 | -12.94 | -57.99 |
Net Debt Issued (Repaid) | 14.06 | 17.02 | 52.34 | 22.49 | 5.44 |
Issuance of Common Stock | 163.93 | - | - | - | - |
Other Financing Activities | -24.06 | - | -2.28 | - | - |
Financing Cash Flow | 153.93 | 17.02 | 50.07 | 22.49 | 5.44 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -1.91 | -0.01 | - | - | - |
Net Cash Flow | 1.93 | 0.85 | 4.16 | 0.47 | -10.74 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -150.09 | -16.17 | -45.91 | -22.02 | -15.68 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -37.53% | -4.72% | -15.06% | -8.98% | -7.28% |
Free Cash Flow Per Share | -46.51 | -7.69 | -21.82 | -16.34 | -11.64 |
Levered Free Cash Flow | -102.35 | -10.39 | -26.42 | -12.1 | -215.05 |
Unlevered Free Cash Flow | -94.29 | -2.29 | -17.76 | -2.08 | -204.87 |